Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.
  • Support
  • For Institutionals
Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.
  • Support
  • For Institutionals

Current region:

  • English
    ACTIVE
Other languages:
  • Español – Spanish
  • Português – Portuguese
  • English – International
  • 日本語 – Japanese
Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.

AMD, Palantir, and Super Micro Lead Today’s Stocks to Watch

U.S. stocks are in focus today as investors track key corporate updates across technology, healthcare, and energy. Palantir gained after raising its full-year forecast, while Hims came under pressure following its break with Novo Nordisk and weaker sales. BP also moved higher, supported by improved margins and fresh cost-cutting measures.

Key Points:

  • Palantir rises 6% after lifting its full-year forecast.
  • Hims dropped 10% following a break with Novo Nordisk and disappointing sales.
  • BP gains 2.5% on improved margins and announced cost cuts.

Palantir (PLTR): Momentum from Upward Guidance

Palantir gained 6% in premarket trading after reporting quarterly earnings that surpassed expectations and raising its full-year outlook. The company continues to benefit from growing demand for its AI-driven software offerings.

Hims & Hers (HIMS), Novo Nordisk (NVO): Declines on Partnership Fallout and Weak Results

Shares of Hims fell over 10% after missing revenue estimates. The stock was further pressured by tensions with Novo Nordisk, sparked by Hims’ offering of generic weight-loss medications via its platform.

Vertex Pharmaceuticals (VRTX): Setback Following Clinical Trial Decision

Vertex declined 14% in after-hours trading after announcing it will halt development of its experimental pain treatment, despite promising early-stage data. The decision underscores the company’s reliance on its late-stage pipeline.

DuPont de Nemours (DD): Strong Sales and Upbeat Outlook

DuPont rose 7% in premarket trading after exceeding sales projections and issuing guidance above analyst expectations. Its specialty materials division showed resilience amid uneven end-market demand.

BP (BP), Diageo (DEO): Gains Despite External Pressures

BP advanced 2.5% after reporting stronger profitability metrics and introducing additional cost-saving initiatives. Diageo added 2% despite forecasting a $200 million annual tariff impact.

Advanced Micro Devices (AMD), Super Micro (SMCI), Snap (SNAP): Key Earnings Ahead

Investors are watching earnings reports from AMD, Super Micro Computer, and Snap, all due Tuesday. These results will offer insight into demand trends for high-performance chips, server infrastructure, and social media platforms amid a still-recovering tech landscape.

Related posts

Featured-DailyMarketWatch-EN

Market Commentary 2026-04-30

Daily market commentary featuring timely analysis of price action and economic events. Stay informed with expert observations on the themes
Technical Analysis-EN

USDJPY Near Intervention Levels: Yen Weakens

Yesterday’s Federal Reserve meeting—potentially the last chaired by Jerome Powell—added another layer of uncertainty to markets. While Powell indicated he

Shutterstock_1752291734 (1)

Parabolic SAR Indicator: Strategy and Signals

The Parabolic SAR (Stop and Reverse) is a technical analysis indicator used primarily to identify trend direction and potential reversals